Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation.

[1]  M. Mack,et al.  Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial. , 2019, Journal of the American College of Cardiology.

[2]  M. Mack,et al.  Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial. , 2019, Journal of the American College of Cardiology.

[3]  D. Tousoulis,et al.  THE ASSOCIATION AMONG DEPRESSIVE SYMPTOMS, EMOTIONAL STATUS, AND CAROTID ATHEROSCLEROTIC BURDEN OF THE CORINTHIA STUDY POPULATION , 2019, Journal of the American College of Cardiology.

[4]  S. Sung,et al.  Can Elderly Patients with Severe Mitral Regurgitation Benefit from Trans-catheter Mitral Valve Repair? , 2019, Korean circulation journal.

[5]  M. Mack,et al.  Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial , 2018, American heart journal.

[6]  M. Mack,et al.  Transcatheter Mitral‐Valve Repair in Patients with Heart Failure , 2018, The New England journal of medicine.

[7]  P. Boekstegers,et al.  Prognostic value of preprocedural 6-min walk test in patients undergoing transcatheter mitral valve repair—insights from the German transcatheter mitral valve interventions registry , 2018, Clinical Research in Cardiology.

[8]  A. Sannino,et al.  Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation: A Systematic Review and Meta-analysis , 2017, JAMA cardiology.

[9]  J. Mascherbauer,et al.  Refining the prognostic impact of functional mitral regurgitation in chronic heart failure , 2017, European heart journal.

[10]  Jeroen J. Bax,et al.  Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.

[11]  G. Filippatos,et al.  Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.

[12]  M. Mack,et al.  Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. , 2015, Journal of the American College of Cardiology.

[13]  H. Katus,et al.  Minimal important difference for 6-minute walk test distances among patients with chronic heart failure. , 2014, International journal of cardiology.

[14]  Naoki Sato,et al.  The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.

[15]  A. Curtis,et al.  Clinically Meaningful Change Estimates for the Six‐Minute Walk Test and Daily Activity in Individuals With Chronic Heart Failure , 2013, Cardiopulmonary physical therapy journal.

[16]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[17]  J. Spertus,et al.  Physical Health Status Measures Predict All-Cause Mortality in Patients With Heart Failure , 2013, Circulation. Heart failure.

[18]  R. McKelvie,et al.  6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. , 2012, Journal of the American College of Cardiology.

[19]  K. Dickstein,et al.  Six-Minute Walk Test and Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure: A Comparative Analysis on Clinical and Prognostic Insights , 2009, Circulation. Heart failure.

[20]  W. Kraus,et al.  Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[21]  W. Kraus,et al.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[22]  A. Rigby,et al.  Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. , 2006, European heart journal.

[23]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[24]  ATS Statement , 2002 .